The most represented mutations depend on hereditary or sporadic origin, although some mutations such as that involving cyclin-dependent kinase inhibitor 2A (CDKN2A), a gene that encodes a 156 amino acid, 16 kD cell-cycle inhibitor protein, is common in familial and sporadic melanomas. Here, CDKN2A is linked to melanoma.